These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34793879)

  • 21. Zebrafish as a novel model for non-typhoidal Salmonella pathogenesis, transmission and vaccine efficacy.
    Howlader DR; Sinha R; Nag D; Majumder N; Mukherjee P; Bhaumik U; Maiti S; Withey JH; Koley H
    Vaccine; 2016 Sep; 34(42):5099-5106. PubMed ID: 27614779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota.
    Lawley TD; Bouley DM; Hoy YE; Gerke C; Relman DA; Monack DM
    Infect Immun; 2008 Jan; 76(1):403-16. PubMed ID: 17967858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation by vasoactive intestinal peptide is associated with increased survival and growth of Salmonella Typhimurium in mice.
    Askar B; Higgins J; Barrow P; Foster N
    Cytokine; 2020 Jan; 125():154787. PubMed ID: 31404818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative transcriptional profiling of the early host response to infection by typhoidal and non-typhoidal Salmonella serovars in human intestinal organoids.
    Abuaita BH; Lawrence AE; Berger RP; Hill DR; Huang S; Yadagiri VK; Bons B; Fields C; Wobus CE; Spence JR; Young VB; O'Riordan MX
    PLoS Pathog; 2021 Oct; 17(10):e1009987. PubMed ID: 34669717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Salmonella enterica serovar typhimurium sseK1 on macrophage inflammation-related cytokines and glycolysis.
    Lu X; Yu C; Zhang C; Zhang H; Li Y; Cheng X; Jia Y
    Cytokine; 2021 Apr; 140():155424. PubMed ID: 33513526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phloretin is protective in a murine salmonella enterica serovar typhimurium infection model.
    Zhang Z; Liu S; Huang J; Cui Y; Liu Y; Zhou Y; Zhu Z
    Microb Pathog; 2021 Dec; 161(Pt B):105298. PubMed ID: 34801645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function.
    Boyle EC; Brown NF; Finlay BB
    Cell Microbiol; 2006 Dec; 8(12):1946-57. PubMed ID: 16869830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage.
    Köhler H; Sakaguchi T; Hurley BP; Kase BA; Reinecker HC; McCormick BA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G178-87. PubMed ID: 17615177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.
    Ugrinovic S; Brooks CG; Robson J; Blacklaws BA; Hormaeche CE; Robinson JH
    Infect Immun; 2005 Dec; 73(12):8002-8. PubMed ID: 16299293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice.
    Ganesh BP; Klopfleisch R; Loh G; Blaut M
    PLoS One; 2013; 8(9):e74963. PubMed ID: 24040367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Variability of Serial Human Isolates of Salmonella enterica Serovar Typhimurium Associated with Prolonged Carriage.
    Octavia S; Wang Q; Tanaka MM; Sintchenko V; Lan R
    J Clin Microbiol; 2015 Nov; 53(11):3507-14. PubMed ID: 26311853
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Chu C; Wong MY; Chiu CH; Tseng YH; Chen CL; Huang YK
    Pol J Microbiol; 2019 Dec; 68(4):439-447. PubMed ID: 31880888
    [No Abstract]   [Full Text] [Related]  

  • 33. Salmonella enterica Serovar Typhimurium Exploits Cycling through Epithelial Cells To Colonize Human and Murine Enteroids.
    Geiser P; Di Martino ML; Samperio Ventayol P; Eriksson J; Sima E; Al-Saffar AK; Ahl D; Phillipson M; Webb DL; Sundbom M; Hellström PM; Sellin ME
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits macrophage colonization by Salmonella enterica serovar Typhimurium.
    Buckner MM; Antunes LC; Gill N; Russell SL; Shames SR; Finlay BB
    PLoS One; 2013; 8(7):e69759. PubMed ID: 23922794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    Luo Q; Wan F; Yu X; Zheng B; Chen Y; Gong C; Fu H; Xiao Y; Li L
    J Antimicrob Chemother; 2020 Jan; 75(1):92-95. PubMed ID: 31580437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of defined microbiota is protective in a murine Salmonella infection model.
    Martz SL; McDonald JA; Sun J; Zhang YG; Gloor GB; Noordhof C; He SM; Gerbaba TK; Blennerhassett M; Hurlbut DJ; Allen-Vercoe E; Claud EC; Petrof EO
    Sci Rep; 2015 Nov; 5():16094. PubMed ID: 26531327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid decreases the severity of Salmonella enterica serovar Typhimurium mediated gastroenteritis in a mouse model.
    Sinha R; Howlader DR; Mukherjee P; Rai S; Nag D; Koley H
    Immunobiology; 2016 Jul; 221(7):839-44. PubMed ID: 26858186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic involvement in Salmonella infection.
    Pezzilli R; Morselli-Labate AM; Barakat B; Romboli E; Ceciliato R; Piscitelli L; Corinaldesi R
    JOP; 2003 Nov; 4(6):200-6. PubMed ID: 14614200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-infection by Salmonella enterica subsp. Enterica serovar typhimurium and Entamoeba dispar pathogenic strains enhances colitis and the expression of amoebic virulence factors.
    Silva Oliveira FM; Claúdia de Carvalho Fernandes A; Henrique de Cicco Sandes S; Prata LO; Junior MA; Vilela da Silva CA; Campolina-Silva GH; Lorenzo de Jesus Oliveira M; Oliveira CA; Neumann E; Nunes ÁC; Gomes MA; Caliari MV
    Microb Pathog; 2021 Sep; 158():105010. PubMed ID: 34126224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain.
    Henry MA; Fairchild DD; Patil MJ; Hanania T; Hain HS; Davis SF; Malekiani SA; Hu A; Sucholeiki R; Nix D; Sucholeiki I
    J Oral Facial Pain Headache; 2015; 29(3):286-96. PubMed ID: 26244437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.